Respiratory syncytial virus prevention and therapy: past, present, and future (Q37857806)

24 August 2017

1 reference

title

Respiratory syncytial virus prevention and therapy: past, present, and future (English)

1 reference

24 August 2017

Melvin Wright

1

1 reference

PubMed ID

21438168

24 August 2017

Giovanni Piedimonte

series ordinal

2

1 reference

24 August 2017

23 November 2010

1 reference

24 August 2017

Pediatric Pulmonology

1 reference

24 August 2017

46

1 reference

24 August 2017

4

1 reference

24 August 2017

324-347

1 reference

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

24 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Two distinct subtypes of human respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Variation in severity of respiratory syncytial virus infections with subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Severity of respiratory syncytial virus infection is related to virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

National surveillance for respiratory syncytial virus, United States, 1985-1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Diagnosis and management of bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Seasonal patterns of respiratory syncytial virus infection in Hong Kong: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Prevention and treatment of respiratory syncytial virus infection in infants: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Risk factors for severe respiratory syncytial virus infection in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Maternal smoking, asthma, and bronchiolitis: clear-cut association or equivocal evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus and subsequent lower respiratory tract infections in developing countries: A new twist to an old virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infections in previously healthy working adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory status and allergy after bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Recurrent wheezing in children with respiratory syncytial virus (RSV) bronchiolitis in Qatar

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory status and allergy nine to 10 years after acute bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Quantitative shedding patterns of respiratory syncytial virus in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Modes of transmission of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Possible transmission by fomites of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The histopathology of fatal untreated human respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection in immunocompromised adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Severe RSV bronchiolitis in an immunocompromised child

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Pathological changes in virus infections of the lower respiratory tract in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Neurotrophins in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Mast cells synthesize, store, and release nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Human mast cells express functional TrkA and are a source of nerve growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Neurotrophins: a link between airway inflammation and airway smooth muscle contractility in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Nerve growth factor mediates steroid-resistant inflammation in respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Epidemic infections caused by respiratory syncytial virus in institutionalized young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The radiological findings in respiratory syncytial virus infection in children. II. The correlation of radiological categories with clinical and virological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The radiological findings in respiratory syncytial virus infection in children. Part I. Definitions and interobserver variation in the assessment of abnormalities on the chest X-ray

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Apnea associated with respiratory syncytial virus infection in young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus-related apnea in infants. Demographics and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The association of apnea and respiratory syncytial virus infection in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Risk factors for respiratory syncytial virus associated apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Effect of respiratory syncytial virus on apnea in weanling rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Multiple viral respiratory pathogens in children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Bronchodilators for bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Anti-inflammatory effect of albuterol enantiomers during respiratory syncytial virus infection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Epinephrine for bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Glucocorticoids for acute viral bronchiolitis in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Dexamethasone inhalations in RSV bronchiolitis: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Epinephrine and dexamethasone in children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Variations in bronchiolitis management between five New Zealand hospitals: can we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

The clinical course of bronchiolitis associated with acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Diagnosis and management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Nebulised hypertonic saline for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Nebulized hypertonic saline solution for acute bronchiolitis in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Pulmonary surfactant: a front line of lung host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Surfactant abnormalities in infants with severe viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Surfactant therapy for bronchiolitis in critically ill infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

THE EFFECTS OF INHALATION OF HELIUM MIXED WITH OXYGEN ON THE MECHANICS OF RESPIRATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Heliox therapy in infants with acute bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Noninvasive therapy with helium-oxygen for severe bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Montelukast in RSV-bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Detection of human coronavirus NL63, human metapneumovirus and respiratory syncytial virus in children with respiratory tract infections in south-west Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and goggles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

RSV outbreak in a paediatric intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Costs and benefits of respiratory syncytial virus immunoglobulin to prevent hospitalization for lower respiratory tract illness in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Palivizumab in the prophylaxis of respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Long-term prospective study in children after respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Respiratory problems 2 years after acute bronchiolitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

Continuing respiratory problems three and a half years after acute viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21377

21 January 2018

Identifiers

DOI

10.1002/PPUL.21377

1 reference

24 August 2017

1 reference

PubMed ID

21438168